ALKS - Alkermes downgraded at UBS as stock nears 52-week high
2024-02-20 12:32:42 ET
More on Alkermes
- Alkermes: Additional Narcolepsy Data Could Lead The Way To The Next Stage
- Alkermes to sell Athlone facility in Ireland to Novo Nordisk for $92.5M
- Alkermes Q4 2023 Earnings Preview
- Alkermes plc 2023 Q4 - Results - Earnings Call Presentation
- Alkermes plc (ALKS) Q4 2023 Earnings Call Transcript